HealthLupin recalls over 6 lakh bottles of hypertension drug...

Lupin recalls over 6 lakh bottles of hypertension drug in U.S.: USFDA

-

spot_img

[ad_1]

The USFDA reports states that the affected lot is manufactured at Lupin’s Goa-based manufacturing facility. File

The USFDA reports states that the affected lot is manufactured at Lupin’s Goa-based manufacturing facility. File
| Photo Credit: Reuters

Drug firm Lupin is recalling over six lakh bottles of a medication indicated for high blood pressure in the U.S. due to deviation from current good manufacturing practices (CGMP), according to the U.S. health regulator.

As per its latest Enforcement Report, U.S. Food and Drug Administration (USFDA), stated that Dr. Reddy’s Laboratories is also recalling a product in the U.S. due to a manufacturing issue.

Baltimore-based Lupin Pharmaceuticals Inc, a subsidiary of Mumbai-based Lupin, is recalling 6,16,506 bottles of Ramipril capsules in strengths of 2.5 mg, 5 mg and 10 mg, the U.S. health regulator said.

The affected lot is manufactured at Lupin’s Goa-based manufacturing facility, it stated.

The company is recalling 1,12,770 bottles of 2.5 mg tablets; 1,46,322 bottles of 5 mg tablets and 3,57,414 bottles of 10 mg tablets, it said.

The U.S. health regulator noted that the company is undertaking Class II voluntary recall due to “CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor.” Lupin Pharmaceuticals Inc. initiated the recall on October 23 this year.

As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

In a separate listing, USFDA stated that a U.S.-based unit of Dr. Reddy’s Laboratories is recalling 3,416 Made in India bottles of IBU (ibuprofen) 600 mg tablets in the U.S.

Princeton (NJ) based Dr. Reddy’s Laboratories, Inc initiated the Class III recall due to “Failed Tablet/Capsule Specifications,” USFDA said.

The company initiated the voluntary recall on October 29.

As per the USFDA, a Class III recall is initiated in a “situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.”

[ad_2]

Source link

Latest news

How to Make Real Money With 92 Pak Game

Understanding the Basics of 92 Pak Game 92 Pak Game has gained massive popularity among mobile gamers in Pakistan, primarily...

How UFABET Supports Multilingual Customer Service

In the increasingly globalized world of online betting, providing excellent customer service that caters to a diverse audience is...

Ceritafilm Offers a Journey Through Reviews and Downloads

Explore the World of Cinema Through a Comprehensive Lens For movie enthusiasts who crave more than just a surface-level understanding...

Soft Play Bus Essex for Weddings – Keep Kids Entertained

When planning a wedding, ensuring that every guest enjoys themselves is a priority. However, one challenge many couples face...
spot_img

Luxury on the Move: The Pamper Bus Experience for Children’s Parties

A Glamorous Celebration on Wheels Bringing luxury and fun to your doorstep, the pamper bus is revolutionizing the way children's...

Affordable Luxury Awaits: Grace Bay Turks and Caicos Beachfront Escapes

A Paradise Destination Without the Price Tag Grace Bay Turks and Caicos has long been known as a dream destination...

Must read

How to Make Real Money With 92 Pak Game

Understanding the Basics of 92 Pak Game 92 Pak Game...

How UFABET Supports Multilingual Customer Service

In the increasingly globalized world of online betting, providing...
spot_img

You might also likeRELATED
Recommended to you